全文获取类型
收费全文 | 115169篇 |
免费 | 11885篇 |
国内免费 | 9069篇 |
专业分类
耳鼻咽喉 | 910篇 |
儿科学 | 1278篇 |
妇产科学 | 1333篇 |
基础医学 | 12755篇 |
口腔科学 | 2220篇 |
临床医学 | 16095篇 |
内科学 | 16163篇 |
皮肤病学 | 976篇 |
神经病学 | 6283篇 |
特种医学 | 4154篇 |
外国民族医学 | 70篇 |
外科学 | 11129篇 |
综合类 | 20829篇 |
一般理论 | 15篇 |
预防医学 | 7574篇 |
眼科学 | 3832篇 |
药学 | 12689篇 |
99篇 | |
中国医学 | 7789篇 |
肿瘤学 | 9930篇 |
出版年
2024年 | 134篇 |
2023年 | 1837篇 |
2022年 | 3102篇 |
2021年 | 5672篇 |
2020年 | 5231篇 |
2019年 | 4086篇 |
2018年 | 4058篇 |
2017年 | 3905篇 |
2016年 | 3283篇 |
2015年 | 5480篇 |
2014年 | 7086篇 |
2013年 | 6141篇 |
2012年 | 8902篇 |
2011年 | 9981篇 |
2010年 | 6446篇 |
2009年 | 5115篇 |
2008年 | 6430篇 |
2007年 | 6190篇 |
2006年 | 6298篇 |
2005年 | 5996篇 |
2004年 | 3789篇 |
2003年 | 3558篇 |
2002年 | 3004篇 |
2001年 | 2568篇 |
2000年 | 2676篇 |
1999年 | 2744篇 |
1998年 | 1805篇 |
1997年 | 1720篇 |
1996年 | 1410篇 |
1995年 | 1337篇 |
1994年 | 1125篇 |
1993年 | 694篇 |
1992年 | 805篇 |
1991年 | 667篇 |
1990年 | 584篇 |
1989年 | 525篇 |
1988年 | 459篇 |
1987年 | 387篇 |
1986年 | 313篇 |
1985年 | 245篇 |
1984年 | 103篇 |
1983年 | 69篇 |
1982年 | 50篇 |
1981年 | 41篇 |
1980年 | 29篇 |
1979年 | 32篇 |
1964年 | 2篇 |
1963年 | 1篇 |
1962年 | 1篇 |
1961年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
Xi Tian Yue Wang Wenhao Xu Haidan Tang Shuxuan Zhu Aihetaimujiang Anwaier Wangrui Liu Wenfeng Wang Wenkai Zhu Jiaqi Su Yuanyuan Qu Hailiang Zhang Dingwei Ye 《International journal of cancer. Journal international du cancer》2023,152(1):66-78
In clear cell renal cell carcinoma (ccRCC), glycolysis is enhanced mainly because of the increased expression of key enzymes in glycolysis. Hence, the discovery of new molecular biomarkers for glycolysis may help guide and establish a precise system of diagnosis and treatment for ccRCC. Expression profiles of 1079 tumor samples of ccRCC patients (including 311 patients treated with everolimus or nivolumab) were downloaded from public databases. Proteomic profiles of 232 ccRCC samples were obtained from Fudan University Shanghai Cancer Center (FUSCC). Biological changes, tumor microenvironment and prognostic differences were explored between samples with various glycolysis characteristics. There were significant differences in CD8+ effector T cells, epithelial-to-mesenchymal transition and pan-fibroblast TGFb between the Low and High glyScore groups. The tumor mutation burden of the Low glyScore group was lower than that of the High glyScore group. And higher glyScore was significantly associated with worse overall survival (OS) in 768 ccRCC patients (P < .0001). External validation in FUSCC cohort also indicated that glyScore was of strong ability for predicting OS (P < .05). GlyScore may serve as a biomarker for predicting everolimus response in ccRCC patients due to its significant associations with progression-free survival (PFS). And glyScore may also predict overall survival in patients treated with nivolumab. We calculated the glyScore in ccRCC and the defined glyScore was of strong ability for predicting OS. In addition, glyScore may also serve as a biomarker for predicting PFS in patients treated with everolimus and could predict OS in patients treated with nivolumab. 相似文献
6.
轻度认知障碍(Mild cognition impairment, MCI)是尚未达到阿尔兹海默病(Alzheimer’s disease, AD)的诊断标准且可逆转为正常脑老化状态的最佳窗口期。情志异常、肝失疏泄(肝失疏泄日久致肝郁)已被证实为MCI的重要情志病机,且“长期负性情绪积累肝失疏泄致衰加速脑老化”的科学假说已在本课题组前期研究中得到初步证实,疏肝法干预肝郁型MCI患者疗效显著,但以上作用机制尚未得到完全阐述。因此本研究系统总结了中医学对MCI的认识,长期情绪不调肝失疏泄对MCI的影响及可能机制,疏肝解郁方药及其成分改善肝郁型MCI的可行性,并提出使用无束缚性设计的眼动技术以探索疏肝法改善肝郁型MCI的可行性,为MCI的中医药干预及其神经机制探讨提供新思路,为中医情志衰老学说增添新内涵。 相似文献
7.
Qiang Liu Zhongbiao Xu Kaixuan Zhao W. Scott Hoge Xinyuan Zhang Yingjie Mei Qiqi Lu Thoralf Niendorf Yanqiu Feng 《NMR in biomedicine》2022,35(5):e4652
The purpose of this study was to investigate the feasibility of two-dimensional (2D) navigated, interleaved multishot echo-planar imaging (EPI) to enhance kidney diffusion-weighted imaging (DWI) in rats at 7.0 T. Fully sampled interleaved four-shot EPI with 2D navigators was tailored for kidney DWI (Sprague–Dawley rats, n = 7) on a 7.0-T small bore preclinical scanner. The image quality of four-shot EPI was compared with T2-weighted rapid acquisition with relaxation enhancement (RARE) (reference) and single-shot EPI (ss-EPI) without and with parallel imaging (PI). The contrast-to-noise ratio (CNR) was examined to assess the image quality for the EPI approaches. The Dice similarity coefficient and the Hausdorff distance were used for evaluation of image distortion. Mean diffusivity (MD) and fractional anisotropy (FA) were calculated for renal cortex and medulla for all DWI approaches. The corticomedullary difference of MD and FA were assessed by Wilcoxon signed-rank test. Four-shot EPI showed the highest CNR among the three EPI variants and lowest geometric distortion versus T2-weighted RARE (mean Dice: 0.77 for ss-EPI without PI, 0.88 for ss-EPI with twofold undersampling, and 0.92 for four-shot EPI). The FA map derived from four-shot EPI clearly identified a highly anisotropic region corresponding to the inner stripe of the outer medulla. Four-shot EPI successfully discerned differences in both MD and FA between renal cortex and medulla. In conclusion, 2D navigated, interleaved multishot EPI facilitates high-quality rat kidney DWI with clearly depicted intralayer and interlayer structure and substantially reduced image distortion. This approach enables the anatomic integrity of DWI-MRI in small rodents and has the potential to benefit the characterization of renal microstructure in preclinical studies. 相似文献
8.
目的 评价美国国家电器制造协会(National Electrical Manufactures Association, NEMA)最新标准(NU 2-2018)在正电子发射型计算机断层显像/电子计算机断层显像(positron emission tomography/computed tomography, PET/CT)设备性能检测中的作用。 方法 依据最新的NEMA NU 2-2018标准,检测西门子Biograph Vision PET/CT的空间分辨率、灵敏度、散射分数、计数丢失、随机符合、飞行时间分辨率、计数丢失率和随机符合校正精度、图像质量、衰减和散射校正精度及PET与CT配准精度指标。 结果 距视野中心1 cm处横向和轴向空间分辨率分别为3.75 mm和3.76 mm;在视野中心和轴向10 cm处的灵敏度分别为16.83 kcps/MBq和16.67 kcps/MBq;放射性浓度为27.37 kBq/mL时,最大等效噪声计数率为258.26 kcps,散射分数为38.58%;系统时间分辨率为209.82 ps;图像质量模型的对比度恢复系数范围为88.9%~96.2%,背景变异系数范围为2.05%~6.80%,平均肺插件残余误差为2.43%;计数丢失和随机符合校正最大误差为3.9%;距离床板末端 5 cm 和 100 cm处,在距视野中心Y轴1 cm处,PET和CT的配准精度分别为0.46 mm和1.07 mm,在距视野中心X轴20 cm处,PET和CT的配准精度分别为1.06 mm和1.45 mm,在距视野中心Y轴20 cm处PET和CT的配准精度分别为0.85 mm和1.15 mm。 结论 NEMA NU 2-2018标准检测条件更加接近临床,能更好地反映PET/CT设备的系统性能。 相似文献
9.